Skip to content
Recall Observatory FDA recall evidence

Drug product

Mercaptopurine Tablets, USP, 50 mg, packaged in a) 60-count tablets per bottle (NDC 49884-922-02) and b) 250-count tablets per bottle (NDC 49884-922-04), Rx only, Distributed by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977.

D-1659-2012

June 29, 2012

Class II

Product summary

Firm
Prometheus Laboratories Inc.
Event
Event 62772
Status
Terminated
Classification
Class II
Quantity
a) 25,516 bottles; b) 2,569 bottles
Official record key
drug-enforcement:D-1659-2012

Official wording

Reason: Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.

Code information: Lot #s: a) 11A003, 11A004, 11A005, Exp 01/13; 11L071, 11L072, Exp 10/13; b) 11B009, Exp 01/13; 11L073, Exp 10/13

Distribution pattern: Nationwide and Puerto Rico.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.